Zobrazeno 1 - 10
of 402
pro vyhledávání: '"Mitsuyoshi NAKASHIMA"'
Autor:
Naomichi Arima, Tetsuo Iwagawa, Hiroaki Okamura, Masaki J. Fujita, Yusuke Oiso, Mitsuyoshi Nakashima, Toshiyuki Hamada, Yohann White
Publikováno v:
Molecules, Vol 17, Iss 8, Pp 9931-9938 (2012)
Through bioassay-guided isolation, five compounds with growth inhibitory activity on S1T, an adult T-cell leukemia (ATL) cell line, were isolated from the crude methanol extract of the aerial parts of Hyptis verticillata.
Externí odkaz:
https://doaj.org/article/684cfa6bac1f431899d6658fb702a912
Autor:
Gen Tamura, Yasuyuki Sano, Kazuto Hirata, Shinichi Ishioka, Mitsuyoshi Nakashima, Terumasa Miyamoto
Publikováno v:
Allergology International, Vol 54, Iss 4, Pp 615-620 (2005)
Background: Tulobuterol tape is the first long-acting transdermal preparation of a p2-agonist designed to release tulobuterol in an optimal fashion over a 24-hour period. We investigated the additive effect of tulobuterol tape in adult asthma patient
Externí odkaz:
https://doaj.org/article/e2367d00740c4c16a44c2e7cf408e134
Autor:
Ayana Ono, Kazuhiro Kosuge, Masako Waki, Mitsuaki Takahashisi, Hiroshi Yamada, Kazuko Fujimoto, Keiji Matsumoto, Kayo Ichimaru, Mitsuyoshi Nakashima, Keizo Umegaki
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 43:399-402
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caf157f736dab700d5cb73fbad46a01d
https://doi.org/10.3999/jscpt.43.399
https://doi.org/10.3999/jscpt.43.399
Publikováno v:
Pharmacology. 85:41-47
We conducted a double-blind study to evaluate the antipyretic and analgesic effects of a single administration of zaltoprofen, a nonsteroidal anti-inflammatory drug, in patients with acute upper respiratory tract infection. 170 patients were assigned
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::630c0aadd0a7ce484182525dcaa341b8
https://doi.org/10.1159/000268104
https://doi.org/10.1159/000268104
Autor:
Atsushi Sugiyama, Mitsuyoshi Nakashima, Yuji Kumagai, Kunihiko Sahashi, Kazumasa Aizawa, Tomoe Fujita, Yasuhiko Ikeda, Jun Morita
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 40:279-285
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef1b45264fd532989394263cfc52bd89
https://doi.org/10.3999/jscpt.40.279
https://doi.org/10.3999/jscpt.40.279
Publikováno v:
Allergy and Asthma Proceedings. 30:84-94
Fluticasone furoate nasal spray (FFNS) is a novel, enhanced-affinity glucocorticoid administered in a unique side-actuated device for the treatment of allergic rhinitis. No previous clinical studies have compared the efficacy of FFNS with another int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6669914d95c1de87554181f0b436e876
https://doi.org/10.2500/aap.2009.30.3182
https://doi.org/10.2500/aap.2009.30.3182
Autor:
Kyousuke Ishihara, Hisamichi Aizawa, Mitsuyoshi Nakashima, Hiroyuki Taniguchi, Yasuyuki Sano, Ken Ohta, Mitsuru Adachi
Publikováno v:
Respiratory Medicine. 102(7):1055-1064
Summary Objectives To compare the efficacy and safety of the salmeterol/fluticasone propionate combination product with concurrent sustained release theophylline plus fluticasone propionate in adult Japanese patients with persistent asthma. Design Mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::240ffe4d80cceb07eca9c187bd5cf2a1
Publikováno v:
Practica oto-rhino-laryngologica. Suppl.. 2008:1-18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb4ee055157e1905f0bfdeae5f7a8361
https://doi.org/10.5631/jibirinsuppl1986.2008.supplement123_1
https://doi.org/10.5631/jibirinsuppl1986.2008.supplement123_1
Autor:
Mitsuyoshi Nakashima, Sadako Kuno, Yoshikuni Mizuno, Tomoyoshi Kondo, Ichiro Kanazawa, Mitsutoshi Yamamoto, Kazuko Hasegawa, Takashi Abe
Publikováno v:
Movement Disorders. 22:1860-1865
We report the results of a randomized, double-blind, placebo-controlled, 16-week study to evaluate the efficacy and safety of ropinirole, 0.75 to 15.0 mg/day, as an adjunct to levodopa. A total of 243 patients were randomly assigned into placebo or r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a1f6126b8c6b82edc81ffc8f8985b2
https://doi.org/10.1002/mds.21313
https://doi.org/10.1002/mds.21313
Publikováno v:
Cardiovascular Drug Reviews. 15:299-313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::861fbc0063bb3da62c067f905ea80e40
https://doi.org/10.1111/j.1527-3466.1997.tb00338.x
https://doi.org/10.1111/j.1527-3466.1997.tb00338.x